Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Text message nudge could save thousands from pneumonia

NCT ID NCT07659470

First seen Jun 23, 2026 · Last updated Jun 23, 2026

Summary

This study tests whether a simple WhatsApp message reminding people turning 65 in Chile to get their free pneumococcal vaccine can increase vaccination rates. Over 43,000 adults will be randomly assigned to receive the reminder or not, and researchers will track who gets vaccinated within 42 days. If successful, this low-cost approach could be used to boost vaccine coverage in other populations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTH PROMOTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Immunization Program, Ministry of Health, Chile.

    Santiago, RM, 8320064, Chile

    Contact

    Contact Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

WhatsApp text message reminder

What this could lead to

If it works, this could show that simple text reminders are a cheap, effective way to get more older adults vaccinated against pneumonia.

What could go wrong

This is a behavioral study, not a drug trial. The effect may be small, and results from Chile may not apply to other countries or age groups.

Conditions

The condition(s) this trial relates to.

Pneumococcal Infections

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.